Beyond lithium: expanding treatment for and management of bipolar disorder
2024
Expanding Treatment Options for Bipolar Disorder
Editorial
Conclusion
New treatment options and insights into bipolar disorder management are emerging, particularly for those resistant to lithium.
Supporting Evidence
- Bipolar disorder affects 1-3% of the global population and has a high suicide attempt rate.
- Lithium has been the standard treatment for bipolar disorder for decades but has limitations.
- New treatments like ketamine show promise for treatment-resistant bipolar disorder.
Takeaway
Bipolar disorder is a serious mood condition, and while lithium has been the main treatment, there are now new options that might help people who don't respond to it.
Limitations
The evidence quality for some treatments, like ketamine, is limited.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website